A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (Case reports)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (Case reports)

Published:2008-06-04 Issue:9 Volume:246 Page:1235-1239
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Torres-Soriano Mitzy E.,García-Aguirre Gerardo,Kon-Jara Verónica,Ustariz-Gonzáles Orlando,Abraham-Marín Maura,Ober Michael D.,Quiroz-Mercado Hugo

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00417-008-0856-x.pdf

Reference15 articles.

1. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363–372

2. Battaglia Parodi M, Da Pozzo S, Ravalico G (2003) Photodynamic therapy in chronic central serous chorioretinopathy. Retina 23:235–237

3. Bujarborua D (2005) CSR: Idiopathic central serous chorioretinopathy. Jaypee Brothers, New Delhi

4. Burumcek E, Mudun A, Karacorlu S, Arslan MO (1997) Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. Ophthalmology 104:616–622

5. Cardillo Piccolino F, Eandi CM, Ventre L et al (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752–763

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central serous chorioretinopathy: An evidence-based treatment guideline;Progress in Retinal and Eye Research;2024-07

2. Central serous chorioretinopathy;Macular Diseases - An Update;2024-05-22

3. Current and emerging treatment options for central serous chorioretinopathy;Expert Review of Ophthalmology;2024-04-10

4. Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-01-15

5. Changes in Aqueous Concentrations of Various Cytokines after Intravitreal Bevacizumab Injection for Chronic Central Serous Chorioretinopathy;Korean Journal of Ophthalmology;2023-12-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3